
Alnylam Pharmaceuticals, Inc.
USD293.52
+2.15 (+0.74%)
CEO
Yvonne L. Greenstreet
IPO Date
2004-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$295.96
Prev. Close
$291.37
Day Low
$292.01
Day High
$295.96
52W Low
$273.11
52W High
$495.55
Market Cap
$39.19B
Volume
1.34M
| 1 May 2026 |
| Wells Fargo |
| Equal Weight |
| Equal Weight |
| maintain |
| 1 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 13 Apr 2026 | Truist Securities | Buy | Buy | maintain |
| 25 Mar 2026 | Chardan Capital | Buy | Buy | maintain |
| 25 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 16 Mar 2026 | Jefferies | Buy | Hold | downgrade |
| 18 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |